Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is 4.18% vs -25.79% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 13.02% vs -27.50% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 12.69% vs -16.92% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -14.29% vs -44.74% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Lushang Freda Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 4.18% vs -25.79% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -11.83% vs -13.66% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 13.02% vs -27.50% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -14.32% vs 3.36% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 12.69% vs -16.92% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -17.13% vs 1.56% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -14.29% vs -44.74% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -82.52% vs -58.30% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






